Abstract
Molecular diagnostics enables the early detection of diseases and conditions,
the selection of targeted, individualised treatment options and the monitoring
of treatment efficacy. Tests are available for a wide variety of diseases and
conditions ranging from cancer to cardiovascular disease to cystic fibrosis.
Molecular diagnostics is the fastest-growing segment of the in vitro
diagnostics industry and it is poised to deliver strong double-digit annual
growth over the next several years. It is therefore an attractive segment to
be involved in.
A relatively large number of molecular diagnostics manufacturing companies
exist today. This unique report profiles the Top 100 of them. These are the
companies with the experience, know-how and resources that enables them to
consistently bring to market, cutting-edge and industry leading tests,
reagents, technologies, instrumentation, platforms, systems and software.
The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide is the
third in a highly successful series of reports that already includes The Top
100 In-Vitro Diagnostics Manufacturing Companies in Europe and The Top 100
Point-Of-Care Manufacturing Companies Worldwide.
Research Facts' reports help you make informed decisions about the markets and
organisations that affect your business.
- Learn more about your target markets and target organisations
- Top-level research on all 100 major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations
Profile information for each company in the report typically includes:
- Company Contact Information Address, Telephone and Fax Numbers, Email and
Website Address
- Key Company Decision Makers - From CEO and Main Board to Key Senior
Managers
- Specialised fields such as Company Description, Products, Technology,
Number of Employees and Turnover
| 
View Cart
